|
|
|
Insider
Information: |
Musso Alan A |
Relationship: |
CFO and Treasurer |
City: |
Winston-Salem |
State: |
NC |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
84,347 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$31,537 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
84,347 |
|
|
Total
Value |
$31,537 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Gyre Therapeutics |
GYRE |
SVP, Fin+Admin, CFO & ... |
2014-10-17 |
57,799 |
|
0 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
CFO and Treasurer |
2018-05-25 |
26,548 |
2014-12-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
50 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GYRE |
Gyre Therapeutics |
VP, CFO, Treasurer & Secretary |
|
2006-04-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,799 |
|
- |
|
GYRE |
Gyre Therapeutics |
VP, CFO & Treasurer |
|
2008-08-13 |
4 |
OE |
$1.75 |
$13,610 |
D/D |
7,777 |
5,076 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP, CFO & Treasurer |
|
2008-08-13 |
4 |
S |
$10.00 |
$77,770 |
D/D |
(7,777) |
2,799 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP, CFO & Treasurer |
|
2008-08-14 |
4 |
OE |
$1.75 |
$2,840 |
D/D |
1,623 |
4,422 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP, CFO & Treasurer |
|
2008-08-14 |
4 |
S |
$10.00 |
$16,230 |
D/D |
(1,623) |
2,799 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP, CFO & Treasurer |
|
2008-08-15 |
4 |
OE |
$1.75 |
$1,050 |
D/D |
600 |
3,399 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP, CFO & Treasurer |
|
2008-08-15 |
4 |
S |
$10.00 |
$6,000 |
D/D |
(600) |
2,799 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP, CFO & Treasurer |
|
2009-07-28 |
4 |
S |
$11.02 |
$33,479 |
D/D |
(3,037) |
2,799 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP, CFO & Treasurer |
|
2009-07-28 |
4 |
OE |
$1.75 |
$5,315 |
D/D |
3,037 |
5,836 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP, CFO & Treasurer |
|
2009-07-29 |
4 |
OE |
$1.75 |
$9,210 |
D/D |
5,263 |
8,062 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP, CFO & Treasurer |
|
2009-07-29 |
4 |
S |
$11.05 |
$59,404 |
D/D |
(5,263) |
2,799 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP, CFO & Treasurer |
|
2009-08-07 |
4 |
OE |
$1.75 |
$9,975 |
D/D |
5,700 |
8,499 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP, CFO & Treasurer |
|
2009-08-07 |
4 |
S |
$12.02 |
$68,555 |
D/D |
(5,700) |
2,799 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP, CFO & Treasurer |
|
2009-09-04 |
4 |
S |
$15.07 |
$120,528 |
D/D |
(8,000) |
2,799 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP, CFO & Treasurer |
|
2009-09-04 |
4 |
OE |
$1.75 |
$14,000 |
D/D |
8,000 |
10,799 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP, CFO & Treasurer |
|
2009-12-11 |
4 |
OE |
$1.75 |
$65,140 |
D/D |
37,223 |
40,022 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP, CFO & Treasurer |
|
2009-12-11 |
4 |
S |
$21.53 |
$801,262 |
D/D |
(37,223) |
2,799 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP, CFO & Treasurer |
|
2009-12-15 |
4 |
OE |
$5.10 |
$60,226 |
D/D |
11,809 |
14,608 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP, CFO & Treasurer |
|
2009-12-15 |
4 |
S |
$22.31 |
$263,427 |
D/D |
(11,809) |
2,799 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP, CFO & Treasurer |
|
2009-12-16 |
4 |
OE |
$5.10 |
$5,100 |
D/D |
1,000 |
3,799 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP, CFO & Treasurer |
|
2009-12-16 |
4 |
S |
$22.27 |
$22,269 |
D/D |
(1,000) |
2,799 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
SVP, CFO & Treasurer |
|
2010-05-17 |
4 |
S |
$24.21 |
$212,745 |
D/D |
(8,782) |
2,799 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
SVP, CFO & Treasurer |
|
2010-05-17 |
4 |
OE |
$2.93 |
$43,959 |
D/D |
8,782 |
3,181 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
SVP, CFO & Treasurer |
|
2010-05-18 |
4 |
OE |
$2.93 |
$10,032 |
D/D |
3,424 |
6,223 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
SVP, CFO & Treasurer |
|
2010-05-18 |
4 |
S |
$24.70 |
$84,572 |
D/D |
(3,424) |
2,799 |
0 |
- |
|
50 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|